Table of Content
1. INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICES TREATMENT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2. MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 ARRIVING AT THE MIDDLE EAST AND AFRICA CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICES TREATMENT MARKET
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 MARKET GUIDE
2.2.4 COMPANY POSITIONING GRID
2.2.5 COMAPANY MARKET SHARE ANALYSIS
2.2.6 MULTIVARIATE MODELLING
2.2.7 TOP TO BOTTOM ANALYSIS
2.2.8 STANDARDS OF MEASUREMENT
2.2.9 VENDOR SHARE ANALYSIS
2.2.10 SALES VOULME
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 MIDDLE EAST AND AFRICA CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICES TREATMENT MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3. MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
5.1 PESTLE ANALYSIS
5.2 PORTER’S ANALYSIS
5.3 PATENT ANALYSIS
5.4 TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTICS
5.5 INTRA-ABDOMINAL PRESSURE MEASUREMENT DEVICES MARKET ANALYSIS (QUALITATIVE AND QUANTITATIVE ANALYSIS)
6. INDUSTRY INSIGHTS
6.1 KEY PRICING STRATEGIES
6.2 INTERVIEWS WITH DIAGNOSTIC COMPANIES
6.3 INTERVIEWS WITH PHYSICIANS
6.4 INTERVIEWS WITH RESEARCH SCHOLARS
6.5 OTHER KOL SNAPSHOTS
7. REGULATORY FRAMEWORK
8. MIDDLE EAST AND AFRICA CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICES TREATMENT MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 CAPILLARY BLOOD COLLECTION DEVICES
8.2.1 LANCETS
8.2.1.1. BY TYPE
8.2.1.1.1. SAFETY LANCETS
8.2.1.1.2. LASER LANCET
8.2.1.1.3. HEEL PUNCTURE LANCETS
8.2.1.1.4. CONTACT-ACTIVATED LANCET
8.2.1.1.5. HOMECARE LANCETS
8.2.1.1.6. OTHERS
8.2.1.2. BY FLOW
8.2.1.2.1. LOW FLOW
8.2.1.2.2. MEDIUM FLOW
8.2.1.2.3. HIGH FLOW
8.2.2 MICRO-CONTAINER TUBES
8.2.2.1. BY MATERIAL
8.2.2.1.1. PLASTIC
8.2.2.1.2. GLASS
8.2.2.1.3. STAINLESS STEEL
8.2.2.1.4. OTHERS
8.2.2.2. BY TYPE
8.2.2.2.1. SERUM TUBES
8.2.2.2.2. SERUM-SEPARATING TUBES
8.2.2.2.3. RAPID SERUM TUBES
8.2.2.2.4. EDTA TUBES
8.2.2.2.5. COAGULATION TUBES
8.2.2.2.6. HEPARIN TUBES
8.2.2.2.7. PLASMA SEPARATOR TUBE
8.2.2.2.8. ERYTHROCYTE SEDIMENTATION RATE (ESR) TUBES
8.2.2.2.9. OTHERS
8.2.3 MICRO-HEMATOCRIT TUBES
8.2.3.1. BY TYPE
8.2.3.1.1. HEPARINIZED
8.2.3.1.2. NON- HEPARINIZED
8.2.3.2. BY MATERIAL
8.2.3.2.1. PLASTIC
8.2.3.2.2. GLASS
8.2.3.2.3. STAINLESS STEEL
8.2.3.2.4. OTHERS
8.2.4 WARMING DEVICES
8.2.5 BLOOD BAGS
8.2.5.1. SINGLE BLOOD BAG
8.2.5.2. DOUBLE BLOOD BAG
8.2.5.3. TRIPLE BLOOD BAG
8.2.5.4. OTHERS
8.2.6 TUBE HOLDER
8.2.7 OTHERS
8.3 BLOOD SAMPLING DEVICES
8.3.1 NEEDLES AND SYRINGES
8.3.2 NEEDLE PROTECTION DEVICE
8.3.3 BLOOD TRANSFER UNIT
8.3.4 TUBE HOLDER
8.3.5 HAEMATOCRIT READER
8.3.6 VIALS
8.3.7 OTHERS
8.4 AUTO-INJECTION BASED DEVICES
8.4.1 PEDIATRIC
8.4.2 ADULT BASED
8.5 REMOTE CAPILLARY BLOOD COLLECTION DEVICE
8.5.1 BY PRODUCT
8.5.2 COLLECTION KITS
8.5.2.1. 10 µL
8.5.2.2. 20 µL
8.5.2.3. 30 µL
8.5.3 CARTRIDGE
8.5.4 CLAMSHELL
8.5.5 AUTORACK
8.6 WEARABLE CAPILLARY BLOOD COLLECTION DEVICE
8.6.1 NEEDLE FREE
8.6.2 MICRONEEDLE
8.7 OTHERS
9. MIDDLE EAST AND AFRICA CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICES TREATMENT MARKET, BY MODALITY
9.1 OVERVIEW
9.2 MANUAL DEVICES
9.3 AUTOMATED DEVICES
10. MIDDLE EAST AND AFRICA CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICES TREATMENT MARKET, BY MATERIAL
10.1 OVERVIEW
10.2 PLASTIC
10.3 GLASS
10.4 STAINLESS STEEL
10.5 CERAMIC
10.6 OTHERS
11. MIDDLE EAST AND AFRICA CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICES TREATMENT MARKET, BY PUNCTURE TYPE
11.1 OVERVIEW
11.2 INCISION
11.3 PUNCTURE
11.3.1 FINGER PUNCTURE
11.3.2 HEEL PUNCTURE
12. MIDDLE EAST AND AFRICA CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICES TREATMENT MARKET, BY PROCEDURE
12.1 OVERVIEW
12.2 CONVENTIONAL
12.3 POINT OF CARE TESTING
13. MIDDLE EAST AND AFRICA CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICES TREATMENT MARKET, BY AGE GROUP
13.1 OVERVIEW
13.2 INFANT
13.3 PEDIATRIC
13.4 ADULT
13.5 GERIATRICS
14. MIDDLE EAST AND AFRICA CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICES TREATMENT MARKET, BY TEST TYPE
14.1 OVERVIEW
14.2 WHOLE BLOOD TEST
14.2.1 CAPILLARY BLOOD COLLECTION DEVICES
14.2.2 BLOOD SAMPLING DEVICES
14.2.3 AUTO-INJECTION BASED DEVICES
14.2.4 REMOTE CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICE
14.2.5 WEARABLE CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICE
14.2.6 SELF-ADMINISTERED BLOOD COLLECTOR DEVICE
14.2.7 OTHERS
14.3 PLASMA/ SERUM PROTEIN TESTS
14.3.1 CAPILLARY BLOOD COLLECTION DEVICES
14.3.2 BLOOD SAMPLING DEVICES
14.3.3 AUTO-INJECTION BASED DEVICES
14.3.4 REMOTE CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICE
14.3.5 WEARABLE CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICE
14.3.6 SELF-ADMINISTERED BLOOD COLLECTOR DEVICE
14.3.7 OTHERS
14.4 COMPREHENSIVE METABOLIC PANEL (CMP) TESTS
14.4.1 CAPILLARY BLOOD COLLECTION DEVICES
14.4.2 BLOOD SAMPLING DEVICES
14.4.3 AUTO-INJECTION BASED DEVICES
14.4.4 REMOTE CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICE
14.4.5 WEARABLE CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICE
14.4.6 SELF-ADMINISTERED BLOOD COLLECTOR DEVICE
14.4.7 OTHERS
14.5 LIVER PANEL / LIVER PROFILE/ LIVER FUNCTION TESTS
14.5.1 CAPILLARY BLOOD COLLECTION DEVICES
14.5.2 BLOOD SAMPLING DEVICES
14.5.3 AUTO-INJECTION BASED DEVICES
14.5.4 REMOTE CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICE
14.5.5 WEARABLE CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICE
14.5.6 SELF-ADMINISTERED BLOOD COLLECTOR DEVICE
14.5.7 OTHERS
14.6 DRIED BLOOD SPOT TESTS
14.6.1 CAPILLARY BLOOD COLLECTION DEVICES
14.6.2 BLOOD SAMPLING DEVICES
14.6.3 AUTO-INJECTION BASED DEVICES
14.6.4 REMOTE CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICE
14.6.5 WEARABLE CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICE
14.6.6 SELF-ADMINISTERED BLOOD COLLECTOR DEVICE
14.6.7 OTHERS
14.7 OTHERS
15. MIDDLE EAST AND AFRICA CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICES TREATMENT MARKET, BY APPLICATION
15.1 OVERVIEW
15.2 DIAGNOSTIC
15.2.1 INFECTIOUS DISEASES
15.2.1.1. CAPILLARY BLOOD COLLECTION DEVICES
15.2.1.2. BLOOD SAMPLING DEVICES
15.2.1.3. AUTO-INJECTION BASED DEVICES
15.2.1.4. REMOTE CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICES
15.2.1.5. WEARABLE CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICE
15.2.1.6. SELF-ADMINISTERED BLOOD COLLECTOR DEVICE
15.2.1.7. OTHERS
15.2.2 NON-INFECTIOUS DISEASES
15.2.2.1. CAPILLARY BLOOD COLLECTION DEVICES
15.2.2.2. BLOOD SAMPLING DEVICES
15.2.2.3. AUTO-INJECTION BASED DEVICES
15.2.2.4. REMOTE CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICES
15.2.2.5. WEARABLE CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICES
15.2.2.6. SELF-ADMINISTERED BLOOD COLLECTOR DEVICE
15.2.2.7. OTHERS
15.2.3 OTHERS
15.3 TREATMENT
15.3.1 CAPILLARY BLOOD COLLECTION DEVICES
15.3.2 BLOOD SAMPLING DEVICES
15.3.3 AUTO-INJECTION BASED DEVICES
15.3.4 REMOTE CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICES
15.3.5 WEARABLE CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICE
15.3.6 SELF-ADMINISTERED BLOOD COLLECTOR DEVICE
15.3.7 OTHERS
16. MIDDLE EAST AND AFRICA CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICES TREATMENT MARKET, BY TECHNOLOGY
16.1 OVERVIEW
16.2 VOLUMETRIC ABSORPTIVE MICROSAMPLING
16.3 VENIPUNCTURE
16.4 CAPILLARY ELECTROPHORESIS-BASED CHEMICAL ANALYSIS
16.5 OTHERS
17. MIDDLE EAST AND AFRICA CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICES TREATMENT MARKET, BY END USER
17.1 OVERVIEW
17.2 HOSPITALS
17.3 CLINICS
17.4 PATHOLOGY LABORATORIES
17.5 BLOOD BANKS
17.6 RESEARCH & ACADEMIC LABORATORIES
17.7 HOME CARE SETTING
17.8 OTHERS
18. MIDDLE EAST AND AFRICA CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICES TREATMENT MARKET, BY END USER
18.1 OVERVIEW
18.2 DIRECT TENDER
18.3 RETAIL SALES
18.4 OTHERS
19. MIDDLE EAST AND AFRICA CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICES TREATMENT MARKET, BY GEOGRAPHY
MIDDLE EAST AND AFRICA CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICES TREATMENT MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
19.1 SOUTH AFRICA
19.2 ISRAEL
19.3 SAUDI ARABIA
19.4 UAE
19.5 REST OF MIDDLE EAST AND AMERICA
20. MIDDLE EAST AND AFRICA CAPILLARY BLOOD COLLECTION AND SAMPLING DEVICES TREATMENT MARKET, COMPANY LANDSCAPE
20.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
20.2 MERGERS & ACQUISITIONS
20.3 NEW PRODUCT DEVELOPMENT & APPROVALS
20.4 EXPANSIONS & PARTNERSHIP
20.5 REGULATORY CHANGES
21. COMPANY PROFILE
21.1 BD
21.1.1 COMPANY OVERVIEW
21.1.2 REVENUE ANALYSIS
21.1.3 GEOGRAPHIC PRESENCE
21.1.4 PRODUCT PORTFOLIO
21.1.5 RECENT DEVELOPMENTS
21.2 IMPROVE MEDICAL
21.2.1 COMPANY OVERVIEW
21.2.2 REVENUE ANALYSIS
21.2.3 GEOGRAPHIC PRESENCE
21.2.4 PRODUCT PORTFOLIO
21.2.5 RECENT DEVELOPMENTS
21.3 HEBEI XINLE SCI&TECH CO., LTD.
21.3.1 COMPANY OVERVIEW
21.3.2 GEOGRAPHIC PRESENCE
21.3.3 PRODUCT PORTFOLIO
21.3.4 RECENT DEVELOPMENTS
21.4 TERUMO MEDICAL CORPORATION
21.4.1 COMPANY OVERVIEW
21.4.2 REVENUE ANALYSIS
21.4.3 GEOGRAPHIC PRESENCE
21.4.4 PRODUCT PORTFOLIO
21.4.5 RECENT DEVELOPMENTS
21.5 SARSTEDT AG & CO. KG
21.5.1 COMPANY OVERVIEW
21.5.2 REVENUE ANALYSIS
21.5.3 GEOGRAPHIC PRESENCE
21.5.4 PRODUCT PORTFOLIO
21.5.5 RECENT DEVELOPMENTS
21.6 GREINER BIO-ONE PREANALYTICS
21.6.1 COMPANY OVERVIEW
21.6.2 GEOGRAPHIC PRESENCE
21.6.3 REVENUE ANALYSIS
21.6.4 PRODUCT PORTFOLIO
21.6.5 RECENT DEVELOPMENTS
21.7 BIO RAD LABORATORIES
21.7.1 COMPANY OVERVIEW
21.7.2 GEOGRAPHIC PRESENCE
21.7.3 PRODUCT PORTFOLIO
21.7.4 RECENT DEVELOPMENTS
21.8 INTERVAC TECHNOLOGY
21.8.1 COMPANY OVERVIEW
21.8.2 GEOGRAPHIC PRESENCE
21.8.3 PRODUCT PORTFOLIO
21.8.4 RECENT DEVELOPMENTS
21.9 TRAJAN SCIENTIFIC AND MEDICAL
21.9.1 COMPANY OVERVIEW
21.9.2 REVENUE ANALYSIS
21.9.3 GEOGRAPHIC PRESENCE
21.9.4 PRODUCT PORTFOLIO
21.9.5 RECENT DEVELOPMENTS
21.10 F. HOFFMANN-LA ROCHE AG
21.10.1 COMPANY OVERVIEW
21.10.2 GEOGRAPHIC PRESENCE
21.10.3 PRODUCT PORTFOLIO
21.10.4 RECENT DEVELOPMENTS
21.11 ICU MEDICAL
21.11.1 COMPANY OVERVIEW
21.11.2 GEOGRAPHIC PRESENCE
21.11.3 PRODUCT PORTFOLIO
21.11.4 RECENT DEVELOPMENTS
21.12 DANAHER CORPORATION
21.12.1 COMPANY OVERVIEW
21.12.2 REVENUE ANALYSIS
21.12.3 GEOGRAPHIC PRESENCE
21.12.4 PRODUCT PORTFOLIO
21.12.5 RECENT DEVELOPMENTS
21.13 LASEC GROUP
21.13.1 COMPANY OVERVIEW
21.13.2 REVENUE ANALYSIS
21.13.3 GEOGRAPHIC PRESENCE
21.13.4 PRODUCT PORTFOLIO
21.13.5 RECENT DEVELOPMENTS
21.14 MEDTRONIC
21.14.1 COMPANY OVERVIEW
21.14.2 REVENUE ANALYSIS
21.14.3 GEOGRAPHIC PRESENCE
21.14.4 PRODUCT PORTFOLIO
21.14.5 RECENT DEVELOPMENTS
21.15 ASP GLOBAL
21.15.1 COMPANY OVERVIEW
21.15.2 REVENUE ANALYSIS
21.15.3 GEOGRAPHIC PRESENCE
21.15.4 PRODUCT PORTFOLIO
21.15.5 RECENT DEVELOPMENTS
21.16 FRESENIUS KABI
21.16.1 COMPANY OVERVIEW
21.16.2 REVENUE ANALYSIS
21.16.3 GEOGRAPHIC PRESENCE
21.16.4 PRODUCT PORTFOLIO
21.16.5 RECENT DEVELOPMENTS
21.17 ABBOTT
21.17.1 COMPANY OVERVIEW
21.17.2 GEOGRAPHIC PRESENCE
21.17.3 PRODUCT PORTFOLIO
21.17.4 RECENT DEVELOPMENTS
21.18 NIPRO MEDICAL CORPORATION
21.18.1 COMPANY OVERVIEW
21.18.2 REVENUE ANALYSIS
21.18.3 GEOGRAPHIC PRESENCE
21.18.4 PRODUCT PORTFOLIO
21.18.5 RECENT DEVELOPMENTS
22. RELATED REPORTS
23. CONCLUSION
24. QUESTIONNAIRE
25. ABOUT DATA BRIDGE MARKET RESEARCH
